Loading company…
Plymouth company developing endovascular medical devices, including the Flex Vessel Prep System for angioplasty procedures.
VentureMed Group, Inc. develops and markets endovascular medical devices, led by its Flex Vessel Prep System, which is designed to optimize percutaneous transluminal angioplasty for arteriovenous access and peripheral arterial disease. Founded in 2012 and based in Plymouth, US, the company is led by CEO Robert Paulson, and John Pigott is noted as its founder. In October 2025 it raised USD 28 million in Series C funding led by new investor S3 Ventures, with returning investor Endeavour Vision also participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in